Dudediligence.

Insight Molecular Diagnostics Inc

IMDXNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 21 →Insiders3 insiders bought $5.7M in 14 open-market buys. No sales.→HoldersBroadwood Capital 38.9%AWM Investment 8.7%Vanguard 2.3%→Financing →PeersClosest companies: MYGN, NTRA, VCYT→

From the filings

Figures

Revenue
$1.7Mlast 12 months
Net income
−$49.4Mlast 12 months
Operating cash flow
−$24.0Mlast 12 months
Cash and equivalents
$17.8Mat the last balance sheet
Shares outstanding
32.6M shareson issue
Every year and quarter →